Login
$ZJYL
$1.86 -$0.04 (2.11%) Close

Company Executives

Officer Age In this role Joined Pay Source
Erqi Wang Also a director
Chief Executive Officer, Director, Chairman of the Board
57 Not stated Not stated Not reported
Ziqiang Wang Also a director
Chief Financial Officer and Director
56 Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 20-F annual report

Directors
5
serving now
Independent
3 of 3
stated in the proxy; 2 not stated
Average tenure
5.0 years
from year joined
CEO also chairs the board
Yes
Erqi Wang
Director Age On board Independent Committees Other public boards Pay Source
Erqi Wang
57 Not stated Not stated None stated None stated Paid as CEO
Ziqiang Wang
56 2021
5 years
Not stated None stated None stated Not stated
Yanru Guo
50 Not stated Independent
Audit Committee · Chair Compensation Committee Nominating and Corporate Governance Committee
None stated Not stated
Oliver St. Clair Franklin
80 Not stated Independent
Compensation Committee · Chair
None stated Not stated
Jiayuan (James) Tong
52 Not stated Independent
Nominating and Corporate Governance Committee · Chair
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. Jin Medical International Ltd has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support